论文部分内容阅读
11月12日,美国心肺血液研究所(NHLBI)公布《2013 AHA/ACC/TOS成人超重和肥胖管理指南》。向初级医疗保健工作者提供有助于患者健康的权威信息为此项更新指南的重点关注内容。肥胖治疗范围扩大将腰围增加列入共病新指南保留了体质指数(BMI),并建议将腰围作为2型糖尿病、心血管疾病和全因死亡的风险标志物。1998年指南推荐对BMI≥30或BMI≥25且伴有两种共病的患者实施治疗,新指南则将治疗范围扩展至BMI≥25且仅伴一种共病的患者,并将腰围增加作为共病之一。新指南将男性和女性腰围分别大于101和89厘米定义为腹型肥胖,但南非等种族人群的阈值较低。指南编写委员会副主席Donna Ryan博士说,即便
On November 12, the American Heart Lung Blood Institute (NHLBI) released the 2013 AHA / ACC / TOS Guidelines for Overweight and Obese Adults. Providing authoritative information for primary health care workers that is helpful to the health of patients is a key focus of this updated guide. Obese Treatment Expands Inclusion of Waist Increases in Comorbid New Guidelines The BMI is retained and waist circumference is recommended as a risk marker for type 2 diabetes, cardiovascular disease and all-cause mortality. The 1998 guidelines recommend the treatment of patients with BMI ≥ 30 or BMI ≥ 25 with two comorbidities, and the new guidelines extend the treatment to patients with a BMI ≥ 25 and only one comorbid comorbidity, with increased waist circumference as One of the common diseases. The new guidelines define waistlines greater than 101 and 89 centimeters for both men and women as abdominal obesity, but lower thresholds for ethnic groups such as South Africa. Dr Donna Ryan, vice chairman of the guidelines writing committee, said even then